100XBio Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$50K
- Investors
-
3
100XBio General Information
Description
Developer of a hybrid cytometry platform designed to automate complex cell biology experiments and t cell therapy research. The company's platform integrates live-cell imaging with post-fixation marker analysis and utilizes gentle liquid exchange without centrifugation, enabling customers to generate high-density antigen-specificity data from limited sample volumes and improve the efficiency of immunotherapy development.
Contact Information
Website
www.100xbio.comCorporate Office
- Woburn, MA
- United States
Corporate Office
- Woburn, MA
- United States
100XBio Timeline
100XBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Seed Round | 25-Apr-2025 | $50K | Completed | Startup | ||
| 6. Angel (individual) | 10-Jan-2026 | Completed | Startup | |||
| 5. Seed Round | 27-Aug-2024 | Completed | Startup | |||
| 4. Accelerator/Incubator | 31-May-2024 | Completed | Startup | |||
| 3. Angel (individual) | 28-Sep-2023 | Completed | Startup | |||
| 2. Accelerator/Incubator | 22-Sep-2023 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
100XBio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
100XBio Patents
100XBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025259746-A1 | Assay method and device for the detection of rare events in cells | Pending | 12-Jun-2024 | ||
| EP-4743778-A2 | Method and device for detecting a cell response | Pending | 12-Jul-2023 | ||
| US-20260210942-A1 | Method and device for detecting a cell response | Pending | 12-Jul-2023 | ||
| WO-2025015241-A2 | Method and device for detecting a cell response | Inactive | 12-Jul-2023 | ||
| WO-2025015241-A3 | Method and device for detecting a cell response | Inactive | 12-Jul-2023 | G01N33/505 |
100XBio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
100XBio Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bioincubator | Accelerator/Incubator | |||
| C2I Accelerator | Accelerator/Incubator | |||
| The Engine | Accelerator/Incubator |
100XBio FAQs
-
When was 100XBio founded?
100XBio was founded in 2023.
-
Where is 100XBio headquartered?
100XBio is headquartered in Woburn, MA.
-
What is the size of 100XBio?
100XBio has 2 total employees.
-
What industry is 100XBio in?
100XBio’s primary industry is Biotechnology.
-
Is 100XBio a private or public company?
100XBio is a Private company.
-
What is the current valuation of 100XBio?
The current valuation of 100XBio is .
-
What is 100XBio’s current revenue?
The current revenue for 100XBio is .
-
How much funding has 100XBio raised over time?
100XBio has raised $530K.
-
Who are 100XBio’s investors?
Bioincubator, C2I Accelerator, and The Engine have invested in 100XBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
